Care Setting

Getting ready to use COVID-19 Vaccines in Community Pharmacies

29 April 2021Superintendent Pharmacists and their teams will need to ensure institutional readiness to enable COVID-19 vaccination in Community Pharmacies

Using chloramphenicol eye products in children under 2 years

29 April 2021Chloramphenicol eye drops that contain boron or borates (borax or boric acid) can be safely used in children under 2 years where indicated.

Using bolus injections in neonates, children and young people

9 April 2021During certain periods, it may be more necessary than normal to give some medicines by bolus injection for neonates, children and young people

Providing patient information leaflets following COVID-19 treatment

31 March 2021Following treatment for COVID-19 with tocilizumab, sarilumab, or steroids, clinicians should provide suitable patient information leaflets at discharge

Summary of COVID-19 medicines guidance: Nutritional and inherited metabolic disorders

30 March 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and nutritional and inherited metabolic…

Using oxygen in care homes during COVID-19

18 February 2021During COVID-19, oxygen in care homes for those with underlying lung conditions may be more needed than normal. Its use needs to be managed by appropriate teams

Planning access to end of life care medicines out-of-hospital during a pandemic

9 February 2021Consider three steps when planning access to end of life care medicines in out-of-hospital settings during a pandemic. Four practice points are also shared.

How is acute hypomagnesaemia treated in adults?

12 January 2021There is no national guidance on the treatment of hypomagnesaemia, and practice varies widely between hospital Trusts. The guidance in this document reflects practice at…

Summary of COVID-19 medicines guidance: Critical care

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and critical care. Our advice…

Extended-release methylphenidate: A review of the pharmacokinetic profiles of available products

23 December 2020This review discusses current NICE recommendations for the use of methylphenidate for the treatment of ADHD and describes the pharmacokinetic differences between the currently available…

SPS - Specialist Pharmacy Service

NHS